Clinical Trial Update: 5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating 5-aza-4'-thio-2'-deoxycytidine (Aza-TdC) in people with advanced solid tumors. The study is sponsored by the National Cancer I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Aza-TdC (5-aza-4'-thio-2'-deoxycytidine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms, Solid Tumors | Phase 1 | Status: RECRUITING